Alendronate
A nonhormonal medication for the treatment of postmenopausal osteoporosis in women. This drug builds healthy bone, restoring some of the bone loss as a result of osteoporosis.
Year introduced: 1997 (1987)
PubMed search builder options
Subheadings:
Tree Number(s): D02.705.429.500.100
MeSH Unique ID: D019386
Registry Number: X1J18R4W8P
Entry Terms:
- Aminohydroxybutane Bisphosphonate
- 4-Amino-1-Hydroxybutylidene 1,1-Biphosphonate
- MK-217
- MK217
- MK 217
- Fosamax
- Alendronate Sodium
- Alendronate Monosodium Salt, Trihydrate
Previous Indexing:
Pharmacologic Action: